Botanical species · safety record

Melittis melissophyllum

The EFSA Compendium of Botanicals holds 15 constituent measurements for Melittis melissophyllum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Melittis melissophyllum L.

15Constituent measurements

0Safety records

4Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
(-)-camphor	Aerial part of plants	Essential oil	3.61 Percent	GC-MS	Resolve DOI
2-hydroxycinnamic acid	Aerial part of plants	Solvent extraction	≤ 2.61 Milligram/100 gram	HPLC-DAD	Resolve DOI
2-hydroxycinnamic acid	Aerial part of plants	Solvent extraction	≥ 0.63 Milligram/100 gram	HPLC-DAD	Resolve DOI
3,4-dihydroxybenzoic acid	Aerial part of plants	Solvent extraction	≤ 8.22 Milligram/100 gram	HPLC-DAD	Resolve DOI
3,4-dihydroxybenzoic acid	Aerial part of plants	Solvent extraction	≥ 2.1 Milligram/100 gram	HPLC-DAD	Resolve DOI
4-hydroxybenzoic acid	Aerial part of plants	Solvent extraction	≤ 110.91 Milligram/100 gram	HPLC-DAD	Resolve DOI
4-hydroxybenzoic acid	Aerial part of plants	Solvent extraction	≥ 30.21 Milligram/100 gram	HPLC-DAD	Resolve DOI
Coumarin	Leaves	Solvent extraction	≤ 14392 Milligram/kilogram	HPLC-DAD	Resolve DOI
Coumarin	Leaves	Solvent extraction	≤ 11125 Milligram/kilogram	HPLC-DAD	Resolve DOI
Coumarin	Leaves	Solvent extraction	≥ 4588 Milligram/kilogram	HPLC-DAD	Resolve DOI
Coumarin	Leaves	Solvent extraction	≥ 3091 Milligram/kilogram	HPLC-DAD	Resolve DOI
Coumarin	Aerial part of plants	—	≤ 38.5 Percent	GC-MS	Resolve DOI
Coumarin	Aerial part of plants	—	≥ 0.2 Percent	GC-MS	Resolve DOI
P-coumaric acid	Aerial part of plants	Solvent extraction	≤ 121.4 Milligram/100 gram	HPLC-DAD	Resolve DOI
P-coumaric acid	Aerial part of plants	Solvent extraction	≥ 40.48 Milligram/100 gram	HPLC-DAD	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Skaltsa-Diamantidis, H., Tsitsa-Tzardi, E., Tzakou, O., Argyriadou, N. Analysis of the essential oil of Melittis melissophyllum L. Subsp. albida Guss. Journal of essential oil research, 1991, vol. 3, no. 5, p. 367-368. DOI
Skrzypczak-Pietraszek, Ewa., Pietraszek, Jacek. Chemical profile and seasonal variation of phenolic acid content in bastard balm (Melittis melissophyllum L., Lamiaceae) . Journal of pharmaceutical and biomedical analysis, 2012, vol. 66, p. 154-161. DOI
Maggi, F., Barboni, L., Caprioli, G., Papa, F., Ricciutelli, M., Sagratini, G., Vittori, S. HPLC quantification of coumarin in bastard balm (Melittis melissophyllum L., Lamiaceae) . Fitoterapia, 2011, vol. 82, no. 8, p. 1215-1221. DOI
Maggi, Filippo., Conti, Fabio., Cristalli, Gloria., Giuliani, Claudia., Papa, Fabrizio., Sagratini, Gianni., Vittori, Sauro. Chemical Differences in Volatiles between Melittis melissophyllum L. subsp melissophyllum and subsp albida (Guss) P. W. Ball (Lamiaceae) Determined by Solid-Phase Microextraction (SPME) Coupled with GC/FID and GC/MS . Chemistry & biodiversity, 2011, vol. 8, no. 2, p. 325-343. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature